Recently, Spina et al. demonstrated that the inhibition of dihydroorotate dehydrogenase (DHODH), involved in the de novo pyrimidine biosynthesis, reduces tumor growth, prolonging the overall survival in a GBM orthotopic mouse model (Spina et al., 2022). This evidence concerns the gene DHODH and glioblastoma.